Company Directory - Pharmaco

Marinus is committed to improving the lives of patients suffering from drug-resistant seizures and CNS disorders. We are developing an investigational drug, ganaxolone, which is an innovative and much needed potential treatment option for children and adults.

Mayne Pharma Group Limited (Mayne Pharma) is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals, providing patients with access to better and more accessible medicines.

A global, family-owned aesthetics and neurotoxin company inspired by more than 110 years of innovation, commitment and trust. Driven by the opportunity to help people look, feel, and live better, Merz earns the confidence of clinicians in aesthetics and neuroscience with a relentless focus on customer service to providers and overall satisfaction for patients.

The MiP Pharma Group is an internationally oriented medium-sized pharmaceutical company based, development and production in Germany and more than 65-year history of the company . With our 270-strong team, we make a reliable and sustainable contribution to the supply of pharmaceuticals in Germany and Europe.

Providing products and services across the full industry value chain, Midas Pharma is a mid-sized pharmaceutical company that provides a wealth of expertise while connecting companies, people and knowledge. Our core competence is project management around pharmaceutical supply chains.

Mobius Medical is an ISO 9001 certified Australian owned CRO established in 2008 providing outstanding clinical trial management and electronic data capture (EDC) services throughout Australia & New Zealand.

In 2015 a team of researchers, drug developers and commercial leaders shared a vision of developing safe and effective drugs to measurably improve mental and behavioral disorders. Over the years since then, the team has dedicated itself to turning its vision into reality.

Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.

We’re a privately owned UK company with a strong track record in bringing high quality, innovative medicines to UK health professionals and their patients. We believe in excellence and delivering on our promises to the NHS, patients, our business partners and each other.

Nektar Therapeutics is a global biopharmaceutical company focused on the discovery and development of novel therapies which selectively modulate the immune system to treat cancer, autoimmune disorders, and chronic inflammatory conditions.

Neuraxpharm is a European leader in pharmaceuticals for disorders affecting the central nervous system (CNS). We are specialists in this field since 1985 and our more than 35 years’ experience bring a broad, unparalleled knowledge into our research and final products.

One global team, with our customers at the centre of everything we do. NextPharma stands out as your pharmaceutical development and manufacturing partner with fast, flexible and tailored solutions for markets worldwide.

Nitto BioPharma's mission is to develop and deliver innovative life-transforming therapies for patients with unmet medical needs. Leveraging the long standing success and track record of Nitto, NBPI has created a new and efficient business unit that allows pharmaceutical products to be brought to market at a fast pace.

Norgine is a leading European specialist pharmaceutical company with a strong global network of partnerships. This enables us to acquire, develop and commercialise innovative products that make a real difference to the lives of patients.

Novavax, Inc. (Nasdaq:NVAX) is a late-stage biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.

A biopharmaceutical company developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. Our goal is to develop first in class drug candidates that prevent the disease instead of controlling it, and we achieve this through our collaboration with pioneer scientists in the field.

Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, immunologic diseases (e.g., complement-mediated diseases and cancers) and central nervous system disorders.

OneSource Specialty Pharma is a leading Indian contract development and manufacturing organization (CDMO) that offers end-to-end pharmaceutical and biologics solutions. Formed through the merger of three CDMO businesses within the Strides Group.